Neurotech International Limited (ASX:NTI)
Australia · Delayed Price · Currency is AUD 0.0140
+0.0010 (7.69%)
Mar 4, 2026, 4:10 PM AEST
Neurotech International Market Cap
Neurotech International has a market cap or net worth of 16.85 million as of March 3, 2026. Its market cap has decreased by -63.25% in one year.
Market Cap
16.85M
Enterprise Value
10.51M
Revenue
7.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since November 4, 2016, Neurotech International's market cap has decreased from 25.09M to 16.85M, a decrease of -32.83%. That is a compound annual growth rate of -4.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 16.85M | -7.14% |
| Dec 31, 2025 | 18.15M | -68.34% |
| Dec 31, 2024 | 57.32M | -6.85% |
| Dec 29, 2023 | 61.53M | 8.18% |
| Dec 29, 2022 | 56.88M | 35.96% |
| Dec 31, 2021 | 41.83M | 65.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 4, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeuroScientific Biopharmaceuticals | 34.92M |
| Avecho Biotechnology | 33.06M |
| Algorae Pharmaceuticals | 29.03M |
| Argenica Therapeutics | 28.26M |
| Patrys | 20.88M |
| Noxopharm | 20.28M |
| Tissue Repair | 10.88M |
| AdAlta | 10.20M |